2018
DOI: 10.20945/2359-3997000000045
View full text
|
Sign up to set email alerts
|
Share

Abstract: The meta-analysis showed evidence favoring the use of CHOC in the management of DM1. However, this benefit was limited to final HbA1c, which was significantly lower in the CHOC than in the control group.